
Comparative analysis of ctDNA monitoring strategies in advanced NSCLC with MET exon 14 skipping mutations treated with ensartinib | npj Precision Oncology
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9GUzhHVDBqZDFCNDNINXVEQkRRUXRQOVY0MHNMZzI3UzJvUWVsWHlobUZPMWxCU0ZmX3RPTFVRUjRad2dwcmF4R1pobXY1Q1RnLVpDZkNNQU5Vb1B3M3I0?oc=5" target="_blank">Comparative analysis of ctDNA monitoring strategies in advanced NSCLC with MET exon 14 skipping mutations treated with ensartinib | npj Precision Oncology</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
